Ali Hariri

1.4k total citations
23 papers, 926 citations indexed

About

Ali Hariri is a scholar working on Molecular Biology, Nephrology and Epidemiology. According to data from OpenAlex, Ali Hariri has authored 23 papers receiving a total of 926 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Nephrology and 4 papers in Epidemiology. Recurrent topics in Ali Hariri's work include Gout, Hyperuricemia, Uric Acid (4 papers), Renal and related cancers (3 papers) and Lysosomal Storage Disorders Research (3 papers). Ali Hariri is often cited by papers focused on Gout, Hyperuricemia, Uric Acid (4 papers), Renal and related cancers (3 papers) and Lysosomal Storage Disorders Research (3 papers). Ali Hariri collaborates with scholars based in United States, United Kingdom and Germany. Ali Hariri's co-authors include Richard P. Lifton, Carol Nelson‐Williams, Kitt Falk Petersen, Gerald I. Shulman, Hakan R. Toka, James Dziura, Sylvie Dufour, Xian‐Man Zhang, Jia Nee Foo and Khalid Mehmood Raja and has published in prestigious journals such as Science, New England Journal of Medicine and Journal of Biological Chemistry.

In The Last Decade

Ali Hariri

21 papers receiving 904 citations

Peers

Ali Hariri

EPIDE

EDM

CCM

NEPHR

Hye Kyoung Song South Korea

Fone‐Ching Hsiao Taiwan

Yusuke Sakamaki Japan

Cemal Nuri Erçin Türkiye

Hiroyuki Ohsaki Japan

Mitsutoshi Oguri Japan

Denise M. Sadlier Ireland

Tomohito Doke United States

Alla Mitrofanova United States

Bryan R. Conway United Kingdom

Hye Kyoung Song South Korea

Ali Hariri

213 ×0.5

254 ×0.8

EPIDE

191 ×0.8

EDM

133 ×0.9

CCM

139 ×1.2

NEPHR

Citations per year, relative to Ali Hariri Ali Hariri (= 1×) peers Hye Kyoung Song

Countries citing papers authored by Ali Hariri

Since Specialization

Citations

This map shows the geographic impact of Ali Hariri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Hariri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Hariri more than expected).

Fields of papers citing papers by Ali Hariri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ali Hariri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Hariri. The network helps show where Ali Hariri may publish in the future.

Co-authorship network of co-authors of Ali Hariri

This figure shows the co-authorship network connecting the top 25 collaborators of Ali Hariri. A scholar is included among the top collaborators of Ali Hariri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ali Hariri. Ali Hariri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Saag, Kenneth G., Nicola Dalbeth, Chang‐Fu Kuo, et al.. (2025). Evaluation of the efficacy and safety of a novel xanthine oxidase inhibitor, tigulixostat, in gout patients with hyperuricemia: Design of the EURELIA 1 and EURELIA 2 studies. Contemporary Clinical Trials. 151. 107843–107843.

Groß, Oliver, Michelle N. Rheault, James F. Simon, et al.. (2025). Prospective Cohort Study in Alport Syndrome Patients Under Standard Therapy. Kidney International Reports. 10(5). 1360–1371.

Batista, Julie L., Ali Hariri, Manish Maski, et al.. (2024). Reduction in kidney function decline and risk of severe clinical events in agalsidase beta–treated Fabry disease patients: a matched analysis from the Fabry Registry. Clinical Kidney Journal. 17(8). sfae194–sfae194. 4 indexed citations

Gansevoort, Ronald T., Ali Hariri, Pascal Minini, et al.. (2022). Venglustat, a Novel Glucosylceramide Synthase Inhibitor, in Patients at Risk of Rapidly Progressing ADPKD: Primary Results of a Double-Blind, Placebo-Controlled, Phase 2/3 Randomized Clinical Trial. American Journal of Kidney Diseases. 81(5). 517–527.e1. 12 indexed citations

Perrone, Ronald D., Ali Hariri, Pascal Minini, et al.. (2022). The STAGED-PKD 2-Stage Adaptive Study With a Patient Enrichment Strategy and Treatment Effect Modeling for Improved Study Design Efficiency in Patients With ADPKD. Kidney Medicine. 4(10). 100538–100538. 7 indexed citations

Tøndel, Camilla, Beth L. Thurberg, Pronabesh DasMahapatra, et al.. (2022). Clinical relevance of globotriaosylceramide accumulation in Fabry disease and the effect of agalsidase beta in affected tissues. Molecular Genetics and Metabolism. 137(4). 328–341. 14 indexed citations

Toka, Hakan R., et al.. (2020). Mitochondrial DNA mutations in renal disease: an overview. Pediatric Nephrology. 36(1). 9–17. 41 indexed citations

Edmonston, Daniel, Matthew T. Roe, Geoffrey A. Block, et al.. (2020). Drug Development in Kidney Disease: Proceedings From a Multistakeholder Conference. American Journal of Kidney Diseases. 76(6). 842–850. 2 indexed citations

Fusco, Gregory, et al.. (2017). A threshold trajectory was revealed by isolating the effects of hemoglobin rate of rise in anemia of chronic kidney disease. Therapeutic Advances in Drug Safety. 8(10). 305–318. 1 indexed citations

10.

Krishnan, Eswar, Bhavik J. Pandya, Bharathi Lingala, Ali Hariri, & Omar Dabbous. (2012). Hyperuricemia and untreated gout are poor prognostic markers among those with a recent acute myocardial infarction. Arthritis Research & Therapy. 14(1). R10–R10. 36 indexed citations

11.

Toka, Hakan R., et al.. (2012). The molecular basis of blood pressure variation. Pediatric Nephrology. 28(3). 387–399. 17 indexed citations

12.

Krishnan, Eswar, Ali Hariri, Omar Dabbous, & Bhavik J. Pandya. (2011). Hyperuricemia and the Echocardiographic Measures of Myocardial Dysfunction. Congestive Heart Failure. 18(3). 138–143. 27 indexed citations

13.

Pandya, Bhavik J., Aylin Riedel, Jason Swindle, et al.. (2011). Relationship between physician specialty and allopurinol prescribing patterns: a study of patients with gout in managed care settings. Current Medical Research and Opinion. 27(4). 737–744. 16 indexed citations

14.

Toka, Hakan R., Okan Toka, Ali Hariri, & Hiep T. Nguyen. (2010). Congenital Anomalies of Kidney and Urinary Tract. Seminars in Nephrology. 30(4). 374–386. 75 indexed citations

15.

Petersen, Kitt Falk, Sylvie Dufour, Ali Hariri, et al.. (2010). Apolipoprotein C3 Gene Variants in Nonalcoholic Fatty Liver Disease. New England Journal of Medicine. 362(12). 1082–1089. 323 indexed citations

16.

Hariri, Ali, et al.. (2008). A comparison of the effective inhalation detector with GC in alcoholism in Khorasan Razavi Legal Medicine Center. Journal of Forensic Medicine. 14(250). 82–84. 1 indexed citations

17.

Sanjad, Sami A., Ali Hariri, Zuheir Habbal, & Richard P. Lifton. (2006). A novel PCLN-1 gene mutation in familial hypomagnesemia with hypercalciuria and atypical phenotype. Pediatric Nephrology. 22(4). 503–508. 11 indexed citations

18.

Wilson, Frederick H., Ali Hariri, Anita Farhi, et al.. (2004). A Cluster of Metabolic Defects Caused by Mutation in a Mitochondrial tRNA. Science. 306(5699). 1190–1194. 256 indexed citations

19.

Andersen, Bogi, Ali Hariri, Mark R. Pittelkow, & Michael G. Rosenfeld. (1997). Characterization of Skn-1a/i POU Domain Factors and Linkage to Papillomavirus Gene Expression. Journal of Biological Chemistry. 272(25). 15905–15913. 29 indexed citations

20.

Hariri, Ali, et al.. (1990). On the validity of Shannon-information calculations for molecular biological sequences. Journal of Theoretical Biology. 147(2). 235–254. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact